As many as 50% of MS patients prematurely discontinue their disease modifying medications. For this study, we will develop a telephone-based talk therapy intervention and then conduct a randomized controlled trial. Patients will be assigned to either 5 weekly 20 minute telephone sessions of psychotherapy or a brief education control condition. We hypothesize that patients undergoing phone therapy will be more likely to indicate they are interested in resuming taking disease modifying medications than patients given brief education and treatment as usual.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
80
A telephone based talk therapy discussing pros and cons of medication use in MS.
Give patients a pamphlet discussing pros and cons of disease modifying therapies
University of Missouri-Kansas City
Kansas City, Missouri, United States
Kessler Rehabillitation Institute
West Orange, New Jersey, United States
Adherence Treatment Survey
Whether the patient indicates if he/she decided to re-initiate disease modifying therapies on a "yes"/"no" question.
Time frame: 10 weeks after enrollment
Adherence Treatment Survey
Whether the patient reports that he/she plans to discuss disease modifying therapies with a care provider on a "yes"/"no" question.
Time frame: 10 weeks after enrollment
Adherence Treatment Survey
Whether the patient reports that he/she plans to discuss disease modifying therapies with a care provider on a "yes"/"no" question.
Time frame: 5 weeks after enrollment
Adherence Treatment Survey
Whether the patient indicates if he/she decided to re-initiate disease modifying therapies on a "yes"/"no" question.
Time frame: 5 weeks after enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.